B. Riley Wealth Advisors Inc. Makes New $2.22 Million Investment in Celestica, Inc. $CLS

Key Points

• B. Riley Wealth Advisors initiated a $2.22 million position in Celestica during the third quarter, while institutional investors collectively own 67.38% of the company’s stock.
• Celestica insiders have been selling shares: executives sold 243,067 shares worth approximately $89.2 million over the past 90 days, reducing insider ownership to 1.10%.
• Despite the stock trading down 9.5% to $323.32, analyst sentiment remains favorable, with 23 Buy ratings, one Hold rating, and a $450.50 consensus price target. The company also exceeded quarterly earnings and revenue expectations.

B. Riley Wealth Advisors Inc. bought a new stake in shares of Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 6,133 shares of the technology company's stock, valued at approximately $2,217,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of CLS. Washington Trust Advisors Inc. purchased a new stake in shares of Celestica during the second quarter worth $28,000. Elevation Wealth Partners LLC bought a new position in shares of Celestica in the third quarter worth $28,000. Ascentis Independent Advisors bought a new position in shares of Celestica in the first quarter worth $29,000. Harbor Investment Advisory LLC bought a new position in shares of Celestica in the second quarter worth $58,000. Finally, Continuum Advisory LLC purchased a new position in shares of Celestica in the second quarter valued at $62,000. 67.38% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, President Todd C. Cooper sold 20,118 shares of the company's stock in a transaction dated Wednesday, September 23rd. The shares were sold at an average price of $360.00, for a total value of $7,242,480.00. Following the sale, the president directly owned 73,252 shares of the company's stock, valued at $26,370,720. This represents a 21.55% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Mandeep Chawla sold 16,117 shares of the company's stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $369.32, for a total transaction of $5,952,330.44. Following the completion of the sale, the chief financial officer directly owned 65,444 shares in the company, valued at $24,169,778.08. This represents a 19.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 243,067 shares of company stock worth $89,200,967. 1.10% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on CLS. Zacks Research lowered Celestica from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 28th. BWS Financial restated a "buy" rating on shares of Celestica in a research note on Tuesday, July 28th. Canadian Imperial Bank of Commerce raised their target price on Celestica from $480.00 to $500.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 29th. UBS Group raised Celestica from a "neutral" rating to a "buy" rating and lifted their target price for the company from $410.00 to $430.00 in a report on Monday, August 24th. Finally, Scotiabank initiated coverage on Celestica in a research report on Tuesday, August 11th. They set a "sector outperform" rating and a $500.00 price target on the stock. Twenty-three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, Celestica currently has a consensus rating of "Moderate Buy" and an average price target of $450.50.

Celestica Trading Down 9.5%

NYSE:CLS opened at $323.32 on Thursday. The firm has a market capitalization of $37.18 billion, a P/E ratio of 47.03 and a beta of 2.01. The company has a quick ratio of 0.68, a current ratio of 1.23 and a debt-to-equity ratio of 0.32. The company has a fifty day moving average of $333.08 and a 200 day moving average of $350.35. Celestica, Inc. has a 52 week low of $244.51 and a 52 week high of $474.02.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last released its quarterly earnings data on Monday, July 27th. The technology company reported $2.54 earnings per share for the quarter, topping the consensus estimate of $2.29 by $0.25. The business had revenue of $4.68 billion during the quarter, compared to analysts' expectations of $4.30 billion. Celestica had a return on equity of 39.96% and a net margin of 7.16%. The business's revenue was up 62.4% on a year-over-year basis. During the same quarter last year, the business posted $1.39 EPS. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. On average, research analysts predict that Celestica, Inc. will post 10.71 earnings per share for the current year.

Celestica Company Profile

Celestica Inc NYSE: CLS is a global provider of design, manufacturing, and supply-chain services for original equipment manufacturers and other technology companies. The company helps customers develop, produce, deploy, and support complex hardware and electronic systems, serving industries such as communications, enterprise technology, aerospace and defense, industrial technology, health care, and semiconductor equipment.

Its services include product design and engineering, printed circuit board and systems assembly, manufacturing, testing, logistics, aftermarket support, and supply-chain management.

Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.